Rani Therapeutics Holdings, Inc. (RANI) vs VAXART, INC. (VXRT)
- Rani Therapeutics Holdings, Inc. RANI 0.64 −5.88%
- VAXART, INC. VXRT 0.45 −2.17%
Rani Therapeutics Holdings, Inc. and VAXART, INC. are both Biotechnology companies. Rani Therapeutics Holdings, Inc. and VAXART, INC. are of similar size ($94.8M and $92.4M). Rani Therapeutics Holdings, Inc. has negative trailing earnings, so its P/E is not meaningful; VAXART, INC. trades at 2.8×. VAXART, INC. grew revenue faster over the last twelve months: 201.1% against 78.7%. VAXART, INC. has the higher net margin (15.9% vs −597.0%) and the higher return on invested capital (134.6% vs 0.00%). Across the 15 metrics below, VAXART, INC. leads on 14 and Rani Therapeutics Holdings, Inc. on 1.
Valuation
Profitability
| Metric | RANI | VXRT | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | (652.78%) | 16.30% | 0.00% |
| Net margin | (596.97%) | 15.88% | 0.00% |
| Free cash flow margin | (402.83%) | 13.74% | 0.00% |
| Return on equity | (155.24%) | 66.97% | (56.36%) |
| Return on assets | (77.54%) | 23.44% | (48.04%) |
| Return on invested capital | 0.00% | 134.59% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack